Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalo Therapeutics (AVTX) Cash from Investing Activities (2016 - 2025)

Avalo Therapeutics' Cash from Investing Activities history spans 10 years, with the latest figure at $2.4 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities changed N/A year-over-year to $2.4 million; the TTM value through Dec 2025 reached -$81.7 million, down 23055.06%, while the annual FY2025 figure was -$81.7 million, 23055.06% down from the prior year.
  • Cash from Investing Activities reached $2.4 million in Q4 2025 per AVTX's latest filing, up from -$13.3 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $2.4 million in Q4 2025 to a low of -$70.9 million in Q2 2025.
  • Average Cash from Investing Activities over 5 years is -$8.2 million, with a median of -$47500.0 recorded in 2022.
  • Peak YoY movement for Cash from Investing Activities: fell 28.57% in 2021, then soared 367.67% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$11000.0 in 2021, then tumbled by 254.55% to -$39000.0 in 2022, then tumbled by 241.03% to -$133000.0 in 2023, then skyrocketed by 367.67% to $356000.0 in 2024, then skyrocketed by 574.44% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for AVTX's Cash from Investing Activities are $2.4 million (Q4 2025), -$13.3 million (Q3 2025), and -$70.9 million (Q2 2025).